Appendix Table D-4Local therapies for colorectal cancer metastases to the liver, study quality Carey and Boden Case Series quality Assessment

ReferenceClearly Defined QuestionWell-Described Study PopulationWell-Described InterventionUse of Validated Outcome MeasuresAppropriate Statistical AnalysisWell-Described ResultsDiscussion/Conclusions Supported by DataRank*
Chua - 2010YesYesYesYesYesYesYesGood
Kosmider - 2011YesYesYesYesYesYesYesGood
Lee – 2012YesNoYesYesYesYesYesFair
Ruers - 2012YesYesYesYesYesYesYesGood
Seki - 2009YesNoYesYesYesYesYesFair
Sguoros - 2011YesYesYesYesYesYesYesGood
Tsutsumi - 2008YesNoYesYesYesYesYesFair
*

A rank of good indicates that all Carey and Boden critera are fulfilled, a rank of fair indicates that one criterion was unfulfilled or it was not possible to assess a criterion given the published information, a rank of poor indicates that two or more criteria were unfulfilled or it was not possible to assess two or more criteria given the published information.

A rank of good indicates that all Carey and Boden critera are fulfilled, a rank of fair indicates that one criterion was unfulfilled or it was not possible to assess a criterion given the published information, a rank of poor indicates that two or more criteria were unfulfilled or it was not possible to assess two or more criteria given the published information.

From: Appendix D, Evidence Tables

Cover of Local Hepatic Therapies for Metastases to the Liver From Unresectable Colorectal Cancer
Local Hepatic Therapies for Metastases to the Liver From Unresectable Colorectal Cancer [Internet].
Comparative Effectiveness Reviews, No. 93.
Belinson S, Chopra R, Yang Y, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.